General Cannabis Corp (CANN)
OTHER OTC:CANN
Want to see CANN full AI Analyst Report?
Top Page
General Cannabis
(OTC:CANN)
Select Model
Select Model
Rating:42Neutral
Price Target:
$0.02
▼(-57.50% Downside)
Action:Reiterated
Date:06/12/26
The score is driven primarily by weak financial performance—negative equity, ongoing net losses, and consistently negative operating/free cash flow—despite some improvement in operating results. Technicals add further pressure with a downtrend versus longer moving averages and negative MACD. Valuation provides limited support because losses make P/E less meaningful and there is no dividend yield.
Positive Factors
Operating profitability improvement
EBIT moving into positive territory indicates the company has begun converting revenue into operating profit, reflecting improved cost structure or mix. Over 2-6 months this supports margin sustainability and gives management scope to prioritize cash generation or reinvestment to pursue scale.
Negative Factors
Negative shareholders' equity
Negative equity materially weakens financial flexibility and raises refinancing and covenant risks. Over the medium term it constrains access to capital markets, increases creditor scrutiny, and elevates dilution or restructuring risk if management cannot restore net worth through profits or capital raises.
Read all positive and negative factors
Positive Factors
Negative Factors
Operating profitability improvement
EBIT moving into positive territory indicates the company has begun converting revenue into operating profit, reflecting improved cost structure or mix. Over 2-6 months this supports margin sustainability and gives management scope to prioritize cash generation or reinvestment to pursue scale.
Read all positive factors
General Cannabis (CANN) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$2.00M
Dividend YieldN/A
Average Volume (3M)152.58K
Price to Earnings (P/E)―
Beta (1Y)-0.14
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees91
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding110,934,220
10 Day Avg. Volume152,002
30 Day Avg. Volume152,580
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)-0.99
Price to Sales (P/S)0.33
P/FCF Ratio-2.78
Enterprise Value/Market Cap11.68
Enterprise Value/Revenue1.71
Enterprise Value/Gross Profit4.01
Enterprise Value/Ebitda27.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
General Cannabis Business Overview & Revenue Model
Company Description
Denver, Colorado-based Trees Corporation, founded in 2013, specializes in delivering products and services to both the regulated cannabis sector and general consumers throughout the United States. Its business activities are organized into distinc...
How the Company Makes Money
null...
General Cannabis Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
12
Very Negative
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.66M | 11.67M | 13.66M | 18.14M | 13.44M | 5.93M |
| Gross Profit | 5.82M | 5.37M | 5.45M | 6.57M | 4.87M | 1.49M |
| EBITDA | 849.74K | 1.14M | 900.75K | -1.64M | -2.84M | -6.12M |
| Net Income | -4.15M | -842.82K | -3.48M | -7.08M | -9.48M | -8.87M |
Balance Sheet | ||||||
| Total Assets | 20.76M | 22.65M | 20.76M | 23.25M | 31.69M | 22.02M |
| Cash, Cash Equivalents and Short-Term Investments | 214.33K | 1.48M | 214.33K | 969.68K | 2.58M | 2.05M |
| Total Debt | 17.31M | 22.79M | 17.31M | 17.88M | 22.54M | 10.15M |
| Total Liabilities | 23.84M | 26.50M | 23.84M | 23.10M | 25.29M | 12.42M |
| Stockholders Equity | -3.07M | -3.93M | -3.07M | 148.16K | 6.41M | 9.61M |
Cash Flow | ||||||
| Free Cash Flow | -704.76K | -1.40M | -704.76K | -1.43M | -2.11M | -2.98M |
| Operating Cash Flow | -654.15K | -1.40M | -654.15K | -1.13M | -2.05M | -2.65M |
| Investing Cash Flow | -50.60K | 55.92K | -50.60K | -304.42K | -1.95M | -978.74K |
| Financing Cash Flow | -50.59K | 2.60M | -50.59K | -184.25K | 4.53M | 4.93M |
General Cannabis Technical Analysis
Negative
0.04
Price Trends
0.02
Negative
0.03
Negative
0.04
Negative
Market Momentum
>-0.01
Negative
38.45
Neutral
79.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CANN, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.04, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 38.45 is Neutral, neither overbought nor oversold. The STOCH value of 79.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CANN.
General Cannabis Risk Analysis
General Cannabis disclosed 33 risk factors in its most recent earnings report. General Cannabis reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
General Cannabis Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $42.59M | -0.88 | -122.57% | ― | -100.00% | 54.21% | |
47 Neutral | $7.56M | -2.83 | -40.66% | ― | 2.00% | 94.31% | |
47 Neutral | $590.87M | -8.38 | 190.87% | ― | -7.30% | -3.31% | |
42 Neutral | $2.00M | -2.37 | ― | ― | ― | ― | |
42 Neutral | $1.13M | -14.53 | -93.87% | ― | -6.14% | -24.22% |
* Healthcare Sector Average
CANN
General Cannabis
0.02
>-0.01
-14.29%
YCBD
cbdMD
0.72
-0.11
-13.25%
AQST
Aquestive Therapeutics
4.71
1.42
43.16%
IMCC
IM Cannabis Corp
0.18
-2.65
-93.60%
IXHL
Incannex Healthcare Limited Sponsored ADR
3.56
-2.44
-40.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.